RecruitingNot ApplicableNCT06624709

The Benefit in Terms of Improvement in Haemoglobin Level at 6 Months in Premature Babies Receiving Alternate Iron Substitution 4 Times a Week Compared to a Daily Substitution


Sponsor

Riccardo Pfister

Enrollment

160 participants

Start Date

Nov 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

BienFer is a double-blinded randomized controlled trial about iron substitution and abdominal pain. Premature babies and low birth weight babies have lower iron stores than term newborns and are therefore at greater risk of iron deficiency and anemia. Iron deficiency could have consequences for cerebral development. Ferric substitution reduces the risk of iron deficiency and anemia. It is common to replace premature babies with iron substitution between 2 weeks and 6 months of life. In practice, the medical staff notice that newborn with iron substitution have abdominal pain and constipation. A study in the adult population shows that alternate iron supplementation versus daily supplementation improved iron absorption, with no difference in hemoglobin level and decrease abdominal pain. Studies in children shows that intermittent iron supplementation do not change hemoglobin and ferritin level and improve adherence. There is no data comparing daily versus alternate supplementation in premature babies. The aim of the study is to evaluate if alternate (4 times/week) iron supplementation is equivalent to daily iron substitution for hemoglobin values in premature babies between 28 0/7 weeks amenorrhea (WA) and 34 6/7 WA, and if it reduces abdominal discomfort and inflammation, and if it improves compliance.


Eligibility

Min Age: 14 DaysMax Age: 14 Days

Inclusion Criteria3

  • Premature babies between 28 0/7WA and 34 6/7 WA
  • Parental consent, postnatal
  • Age of 2 weeks

Exclusion Criteria5

  • anemia < 80g/l at 2 weeks of age
  • Intraventricular Hemorrhage stage III and IV
  • Necrotizing Enterocolitis
  • Enteral feeding less than 100ml/kg/j after 2 weeks of life
  • Congenital disorder

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIron Supplement

The interventional group will receive 2-3mg/kg/day of iron supplementation 4 times per week and the sham comparator will receive 2-3mg/kg/day of iron supplementation 7 times per week


Locations(2)

HUG

Geneva, Canton of Geneva, Switzerland

CHUV

Lausanne, Canton of Vaud, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06624709


Related Trials